BOSTON--(BUSINESS WIRE)--KCR, the international clinical development solutions provider, announced today that its Chief Commercial Officer, Bryan Katz, was honored by healthcare marketing industry trade magazine PM360 as one of their 2020 ELITE 100 award winners.
The PM360 ELITE (Exceptional • Leaders • Innovators • Transformers • Entrepreneurs) Awards represent some of the most influential people in the healthcare industry. Established in 2015, the Awards recognize individuals who have made significant impacts on the healthcare industry. The honorees are selected by the PM360 editorial staff based on their accomplishments, testimonials from clients and colleagues, and supporting materials that reflect the impact of their efforts.
Of the 18 categories of awards, Mr. Katz was honored in the “strategist” category, which highlights “individuals with a sixth sense for what works and the ability to predict what a company will need to do to remain relevant as the industry evolves.”
“I am honored and grateful to be named as one of PM360’s ELITE strategists,” said Katz. “I have had the extreme fortune of working in organizations and with leaders throughout my career that have provided numerous opportunities to grow personally and professionally.
And this award reflects their investment. I feel privileged to now support the growth of KCR and work with such a dedicated and innovative team of clinical research professionals.”
Mike Jagielski, KCR’s President and CEO added: “I am very happy that we have Bryan on the board. His experience and knowledge make significant contribution to KCR strategy and our company commercial development.”
As CCO at KCR, Mr. Katz oversees all commercial aspects of their clinical development solutions and partnerships. Mr. Katz has over 20 years of expertise as a trusted advisor and senior leader within the life science and pharmaceutical industry, with experience in product strategy, deal services, clinical model innovation and commercial operations. Prior to joining KCR, Bryan held senior roles at Syneos Health, IQVIA, PriceWaterhouseCoopers and Abbott Laboratories.
KCR is a clinical development solutions provider for the biotechnology, pharmaceutical, and medical device industries. We support clients with full-service clinical development capabilities across three main areas: Trial Execution, Consulting and Placement. KCR operates across four main regions: North America, Western Europe, Central Europe, and Eastern Europe, with a main operational hub located in Boston, MA. Our strategic hub locations, technical capabilities and solution offerings allow for the optimized delivery of trial execution strategies to develop life-changing therapies. KCR offers access to an estimated population of 1.1 Billion people. For more information visit www.kcrcro.com.
We see the human behind every number.